From the Journals

From cradle to grave, alcohol is bad for the brain


 

There is “compelling” evidence of the harmful effects of alcohol on the brain. The greatest risk occurs during three periods of life that are marked by dynamic brain changes, say researchers from Australia and the United Kingdom.

alcohol in glass alenkadr/Thinkstock

The three periods are:

  • Gestation (conception to birth), which is characterized by extensive production, migration, and differentiation of neurons, as well as substantial apoptosis.
  • Later adolescence (aged 15-19 years), a period marked by synaptic pruning and increased axonal myelination.
  • Older adulthood (aged 65 and beyond), a period associated with brain atrophy. Changes accelerate after age 65, largely driven by decreases in neuron size and reductions in the number of dendritic spines and synapses.

These changes in neurocircuitry could increase sensitivity to the neurotoxic effects of alcohol, Louise Mewton, PhD, of the Center for Healthy Brain Aging, University of New South Wales, Sydney, and colleagues said.

“A life course perspective on brain health supports the formulation of policy and public health interventions to reduce alcohol use and misuse at all ages,” they wrote in an editorial published online Dec. 4 in The BMJ.

Worrisome trends

Research has shown that globally about 10% of pregnant women drink alcohol. In European countries, the rates are much higher than the global average.

Heavy drinking during gestation can cause fetal alcohol spectrum disorder, which is associated with widespread reductions in brain volume and cognitive impairment.

Even low or moderate alcohol consumption during pregnancy is significantly associated with poorer psychological and behavioral outcomes in children, the investigators noted.

In adolescence, more than 20% of 15- to 19-year-olds in European and other high-income countries report at least occasional binge drinking, which is linked to reduced brain volume, poorer white matter development, and deficits in a range of cognitive functions, they added.

In a recent study of older adults, alcohol use disorders emerged as one of the strongest modifiable risk factors for dementia (particularly early-onset dementia), compared with other established risk factors such as high blood pressure and smoking.

Alcohol use disorders are relatively rare in older adults, but even moderate drinking during midlife has been linked to “small but significant” brain volume loss, the authors said.

Dr. Mewton and colleagues said demographic trends may compound the effect of alcohol use on brain health.

They noted that women are now just as likely as men to drink alcohol and suffer alcohol-related problems. Global consumption is forecast to increase further in the next decade.

Although the effects of the COVID-19 pandemic on alcohol intake and related harms remain unclear, alcohol use has increased in the long term after other major public health crises, they added.

Given the data, Dr. Mewton and colleagues called for “an integrated approach” to reducing the harms of alcohol intake at all ages.

“Population-based interventions such as guidelines on low-risk drinking, alcohol pricing policies, and lower drink driving limits need to be accompanied by the development of training and care pathways that consider the human brain at risk throughout life,” they concluded.

The authors have disclosed no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Recommended Reading

National lung cancer screening guidelines may miss younger African American individuals at high risk
MDedge Internal Medicine
How mental health care would look under a Trump vs. Biden administration
MDedge Internal Medicine
Cirrhosis, Child-Pugh score predict ERCP complications
MDedge Internal Medicine
Dripping, dabbing, and bongs: Can’t tell the players without a scorecard
MDedge Internal Medicine
Siblings of patients with bipolar disorder at increased risk
MDedge Internal Medicine
Can mental health teams de-escalate crises in NYC?
MDedge Internal Medicine
50.6 million tobacco users are not a homogeneous group
MDedge Internal Medicine
Patient health suffers amid pandemic health care shortages
MDedge Internal Medicine
Separating myth from reality: The role of cannabinoids in COVID-19
MDedge Internal Medicine
How to identify, evaluate, and treat patients with ‘Percocet use disorder’
MDedge Internal Medicine